Belpointe Asset Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-250
Closed -$2.36K 806
2023
Q1
$2.36K Sell
250
-467
-65% -$4.27K ﹤0.01% 3265
2022
Q4
$7.16K Buy
+717
New +$7.96K ﹤0.01% 2783

Other funds holding AXGN

Belpointe Asset Management's AXGN Position: Q2 2023 in Review

Belpointe Asset Management sold out of Axogen (AXGN) in Q2 2023, closing a stake of 250 shares — an estimated $2.36K sold.

Belpointe Asset Management first reported a position in AXGN in Q4 2022 and held it in 2 quarters. The position peaked at $7.16K in Q4 2022. 134 funds tracked by Wall St. Rank hold AXGN as of Q2 2023.

  • Belpointe Asset Management reported no remaining Axogen position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 250 Axogen shares in Q2 2023, an estimated $2.36K.
  • Belpointe Asset Management first reported a position in Axogen in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Axogen position peaked at $7.16K in Q4 2022.
  • 134 funds tracked by Wall St. Rank held Axogen as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.